Clinical Trial Update: A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer. [Phase 3]

View source ↗

Summary

A Phase III randomized trial compares radiotherapy with radiosensitisation versus intravesical Bacillus Calmette-Guérin therapy for high-risk non-muscle-invasiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guerin (BCG) intravesical therapy (Bacillus Calmette-Guérin)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: High-Risk Non-Muscle Invasive Bladder Cancer | Phase 3 | Status: NOT_YET_RECRUITING